A Spreadsheet Program for Modeling Quantitative Structure-Pharmacokinetic Relationships for Inhaled Volatile Organics in Humans

References

• Beliveau M Krishnan K 2003 In silico approaches for physiologically based pharmacokinetic modeling Salem H Katz SA Alternative Toxicological Methods, CRC Press LLC Boca Raton 479 532
   Google Scholar
• Haddad , S , Pelekis , M and Krishnan , K . 1996 . A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares . Toxicol. Lett. , 85 : 113 – 126 .
   PubMed Web of Science ®Google Scholar
• Krishnan K Andersen ME 2001 Physiologically based pharmacokinetic modeling in toxicology Hayes AW Principles and Methods of Toxicology, Taylor & Francis Philadelphia 193 241
   Google Scholar
• Beliveau , M , Tardif , R and Krishnan , K . 2003 . Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats . Toxicol. Appl. Pharmacol. , 189 : 221 – 232 .
   PubMed Web of Science ®Google Scholar
• Gargas , ML , Burgess , RJ , Voisard , DE , Cason , GH and Andersen , ME . 1989 . Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues . Toxicol. Appl. Pharmacol. , 98 : 87 – 99 .
   PubMed Web of Science ®Google Scholar
• Gargas , ML , Seybold , PG and Andersen , ME . 1988 . Modeling the tissue solubilities and metabolic rate constant (Vmax) of halogenated methanes, ethanes, and ethylenes . Toxicol. Lett. , 43 : 235 – 256 .
   PubMed Web of Science ®Google Scholar
• Haddad , S , Charest-Tardif , G , Tardif , R and Krishnan , K . 2000 . Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures . Toxicol. Appl. Pharmacol. , 167 : 199 – 209 .
   PubMed Web of Science ®Google Scholar
• Poulin , P and Krishnan , K . 1999 . Molecular structure-based prediction of the toxicokinetics of inhaled vapors in humans . Int. J. Toxicol. , 18 : 7 – 18 .
   Web of Science ®Google Scholar
• Tardif , R , Charest-Tardif , G , Brodeur , J and Krishnan , K . 1997 . Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans . Toxicol. Appl. Pharmacol. , 144 : 120 – 134 .
   PubMed Web of Science ®Google Scholar
• Wold , S . 1991 . Validation of QSAR's . QSAR , 10 : 191 – 193 .
   Web of Science ®Google Scholar
• Andersen , ME , Clewell , HJI and Gargas , ML . 1991 . Physiologically-based pharmacokinetic modeling with dichloromethane, its metabolite carbon monoxide and blood carboxyhemoglobin in rats and humans . Toxicol. Appl. Pharmacol. , 108 : 14 – 27 .
   PubMed Web of Science ®Google Scholar
• Ward , RC , Travis , CC , Hetrick , DM , Andersen , ME and Gargas , ML . 1988 . Pharmacokinetics of tetrachloroethylene . Toxicol. Appl. Pharmacol. , 93 : 108 – 117 .
   PubMed Web of Science ®Google Scholar
• Reitz , RH , Mandrela , AL , Corley , RA , Quast , JF , Gargas , ML , Andersen , ME , Staats , DA and Conolly , RB . 1990 . Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically-based pharmacokinetic modeling . Toxicol. Appl. Pharmacol. , 105 : 443 – 459 .
   PubMed Web of Science ®Google Scholar
• Tardif , R , Lapare , S , Charest-Tardif , G , Brodeur , J and Krishnan , K . 1995 . Physiologically-based pharmacokinetic modeling of a mixture of toluene and xylene in humans . Risk Anal. , 15 : 335 – 342 .
   PubMed Web of Science ®Google Scholar
• Ramsey , JC and Andersen , ME . 1984 . A physiologically-based description of the inhalation pharmacokinetics of styrene in rats and humans . Toxicol. Appl. Pharmacol. , 73 : 159 – 175 .
   PubMed Web of Science ®Google Scholar
• Paustenbach , D , Andersen , ME , Clewell , HJ and Gargas , ML . 1988 . A physiologically-based pharmacokinetic model for inhaled carbon tetrachloride in the rat . Toxicol. Appl. Pharmacol. , 96 : 191 – 211 .
   PubMed Web of Science ®Google Scholar
• Tardif , R , Lapare , S , Krishnan , K and Brodeur , J . 1993 . Physiologically based modeling of the toxicokinetic interaction between toluene and m-xylene in the rat . Toxicol. Appl. Pharmacol. , 120 : 266 – 273 .
   PubMed Web of Science ®Google Scholar
• Reitz , RH , Gargas , ML , Andersen , ME , Provan , WM and Green , TL . 1996 . Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic model . Toxicol. Appl. Pharmacol. , 137 : 253 – 267 .
   PubMed Web of Science ®Google Scholar
• Allen , BC and Fisher , JW . 1993 . Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans . Risk Anal. , 13 : 71 – 86 .
   PubMed Web of Science ®Google Scholar
• Fisher , JW , Gargas , ML , Jepson , GW , Allen , B and Andersen , ME . 1991 . Physiologically-based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid in the rat and mouse . Toxicol. Appl. Pharmacol. , 109 : 183 – 195 .
   PubMed Web of Science ®Google Scholar
• Reitz , RH , Gargas , ML , Mendrala , AL and Schumann , AM . 1996 . In vivo in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humans . Toxicol. Appl. Pharmacol. , 136 : 289 – 306 .
   PubMed Web of Science ®Google Scholar
• Andersen , ME , Clewell , HJI , Gargas , ML , Smith , FA and Reitz , RH . 1987 . Physiologically-based pharmacokinetics and risk assessment process for methylene chloride . Toxicol. Appl. Pharmacol. , 87 : 185 – 205 .
   PubMed Web of Science ®Google Scholar